Next Article in Journal
Development and Evaluation of Chitosan-Based Food Coatings for Exotic Fruit Preservation
Previous Article in Journal
In Vitro Anti-HIV-1 Activity of Chitosan Oligomers N-Conjugated with Asparagine and Glutamine
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Fabrication of a Polycaprolactone/Chitosan Nanofibrous Scaffold Loaded with Nigella sativa Extract for Biomedical Applications

by
Qasim Shakir Kahdim
1,2,*,
Najmeddine Abdelmoula
2,
Hassan Al-Karagoly
3,*,
Salim Albukhaty
4,5 and
Jabbar Al-Saaidi
3
1
College of Basic Education, University of Babylon, Babylon 51002, Iraq
2
Laboratory of Multifunctional Materials and Applications (LaMMA), LR16ES18, Faculty of Sciences of Sfax, University of Sfax, BP 1171, Sfax 3000, Tunisia
3
College of Veterinary Medicine, University of Al-Qadisiyah, Al-Diwaniyah 58002, Iraq
4
Department of Chemistry, College of Science, University of Misan, Maysan 62001, Iraq
5
College of Medicine, University of Warith Al-Anbiyaa, Karbala 56001, Iraq
*
Authors to whom correspondence should be addressed.
BioTech 2023, 12(1), 19; https://doi.org/10.3390/biotech12010019
Submission received: 27 December 2022 / Revised: 9 February 2023 / Accepted: 10 February 2023 / Published: 12 February 2023

Abstract

:
In this study, biocompatible electrospun nanofiber scaffolds were produced using poly(-caprolactone (PCL)/chitosan (CS) and Nigella sativa (NS) seed extract, and their potential for biomedical applications was investigated. Scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), total porosity measurements, and water contact angle measurements were used to evaluate the electrospun nanofibrous mats. Additionally, the antibacterial activities of Escherichia coli and Staphylococcus aureus were investigated, as well as cell cytotoxicity and antioxidant activity, using MTT and DPPH assays, respectively. The obtained PCL/CS/NS nanofiber mat was observed by SEM to have a homogeneous and bead-free morphology, with average diameters of 81.19 ± 4.38 nm. Contact angle measurements showed that the wettability of the electrospun PCL/Cs fiber mats decreased with the incorporation of NS when compared to the PCL/CS nanofiber mats. Efficient antibacterial activity against S. aureus and E. coli was displayed, and an in vitro cytotoxic assay demonstrated that the normal murine fibroblast cell line (L929 cells) remained viable after 24, 48, and 72 h following direct contact with the produced electrospun fiber mats. The results suggest that the PCL/CS/NS hydrophilic structure and the densely interconnected porous design are biocompatible materials, with the potential to treat and prevent microbial wound infections.
Key Contribution: Incorporating Nigella sativa extract into the synthesis of PCL/CS nanofibers enhances the electrospinning process, and the resulting material is a biocompatible nanofibrous mat that is low-cost, non-toxic, and has antioxidant and antibacterial properties, making it ideal for use as a wound dressing.

1. Introduction

Electrospinning is an efficient and practical method that utilizes a powerful electric force to move polymeric solutions to create micro- and nanofibers. Surface tension is deformed by the high voltage of an electrically conductive fluid in the fabrication of fibers, which have recently been investigated for their potential in biomedicine, such as in wound treatment and tissue engineering [1,2,3,4,5]. In practical electrospinning, a variety of variables, including melt or solution quality, electrospinning device parameters, and environmental variables, might influence the shape and characteristics of the resulting fibers [6,7]. However, to understand the effects of such complicated parameters on nanofibers when using novel polymers, composites with different mixes, and solvent combinations for electrospinning, extensive research is needed [8,9]. PCL, a synthetic polymer with FDA approval and with considerable mechanical and biocompatibility properties, has been frequently used as a polymer in electrospinning techniques for biomedical applications [10,11,12,13].
Chitosan electrospun nanofibers have gained a great deal of attention in the fields of fibrous wound healing and tissue engineering due to their unique properties, including biocompatibility, biodegradability, antibacterial activity, nontoxicity, antifungal activity, and drug-loading capacity [14,15]. Numerous investigations have been conducted on the electrospinning of chitosan and PCL in conjunction with other polymers or bioactive compounds for use in tissue engineering and wound dressings. Medical plant extracts have been utilized as a traditional treatment for wounds for decades due to their therapeutic effects, which include their antibacterial, antioxidant, anti-inflammatory, and wound-healing effects [16,17]. Nanofibers containing naturally derived bioactive materials are beneficial because of their high specific surface-area-to-volume ratio and extremely porous mesh, which offers a range of advantages for the treatment of both chronic and acute wounds compared to traditional dressings [18]. Nigella sativa (NS) is considered to be one of the most promising herbal products due to the presence of numerous powerful bioactive components, such as thymoquinone [19]. NS has been used for centuries in traditional medicine to treat skin disorders and as an analgesic, liver tonic, diuretic, digestive, anti-diarrheal, and antibacterial treatment [20,21,22,23,24,25]. It has several active ingredients and properties, including antioxidant and anti-inflammatory agents, anti-cancerogenic agents, antimicrobials, and immunostimulants [26,27,28]. Major nutrients in NS include carbohydrates, proteins, alkaloids, vitamins, and minerals. Thymoquinone, which makes up around 45% of its essential oils and is well known for its pharmacological and therapeutic properties, is one of the most prominent components of this plant [29,30]. N. sativa plant extracts and their natural compounds, used in nanoformulations, have demonstrated high activity in the management of wounds and thus can be assumed as future pharmaceutical drugs for prospective application as a wound dressing material. Shiva Teilaghi et al. evaluated an electrospun solution of zein and black seed (Nigella sativa) oil at three different oil concentrations of 5, 10, and 15% w/v in advanced drug delivery applications [31]. Fatemeh Kalhori et al. explored innovative electrospun mats that incorporated NS oil and polyacrylonitrile as a sustained-release nano-bandage to treat rheumatoid arthritis [32]. However, few investigations have focused on the electrospinning of Nigella sativa extract for application in antimicrobial wound dressings. In a recent study, Aras et al. [33]. performed a variety of experiments on the loading of Nigella sativa oil into a polyurethane nanofibrous mat for prospective application as a wound dressing material.
The objective of the current work was to combine the benefits of NS extract with CS and PCL to create a biocompatible nanofibrous mat that was inexpensive, non-toxic, and had antioxidant and antibacterial properties, which could be used as a wound dressing material. In the study, an NS-extract-loaded electrospun PCL/CS nanofibrous mat was investigated for potential use as an antioxidant and antibacterial wound dressing material. The produced mat was characterized by scanning electron microscopy (SEM). FTIR spectroscopy was used to identify the functional groups based on the peak values in the IR present in the native sample. The hydrophilicity of the scaffold was characterized by the surface contact angle test, and the scaffold’s porosity was also investigated. The cytotoxicity of the PCL/CS/NS nanofibrous mat was examined using the L929 cell line, as well as its antioxidant and antibacterial effects on strains of bacteria E. coli and S. aureus.

2. Materials and Methods

2.1. Material

All chemicals used were of analytical grade and were used as received, without any further purification. They were obtained from Sigma-Aldrich as follows: (PCL) Mn ∼80 000, chitosan (CS, molecular weight = 120,000 Da, degree of deacetylation = 85%), phosphate-buffered saline (PBS), Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine serum (FBS), penicillin, streptomycin, dimethyl sulfoxide (DMSO), MTT, acetic acid, and formic acid.
The NS seeds, as raw plant materials, were acquired from a local market in Hilla City, Babylon, Iraq, in February 2022, and were authenticated by the College of Agriculture at the University of Babylon in Iraq. Nigella sativa was extracted following the technique described by H Mahmoudvand et al. [34], with some modifications.

2.2. Gas Chromatography–Mass Spectrometry (GC–MS) Analysis

Using a Perkin Elmer GC/MS-QP2 system and a Restek5, RT*R- (30 m × 0.215 mm) capillary column, the ethanolic extract of N. sativa was examined. The extract (1 mg/mL) was reconstituted in methanol before being injected into 1 μL at a split ratio of 20:1, with 99.9% helium gas as the carrier gas. The oven was gradually heated to 280 °C for 10 min, starting at 60 °C for 5 min, with the inflator at 250 °C. The mass-spectral database (NIST and WILLEY library) connected to the GC/MS system to obtain spectral configurations was used to identify the chemicals [35,36].

2.3. Production of the Electrospun PCL, CS, and NS Nanofibrous Mats

First, various mixtures of PCL/CS and NS extract with different ratios and concentrations were selected for the electrospinning process. The best combination, with an NS/PCL/CS ratio of 2/3/1, was chosen.
The first solution, the NS stock solution, was made by dissolving 0.1 g of NS extract in 100 mL of absolute ethanol (96%). Then, each 1 mL of this stock was supplemented with 5 μL of Tween 80.
A mixture of PCL (10% w/v) and CS (3% w/v) was made by dissolving 1 g of PCL and 0.3 g of CS in 10 mL of glacial acetic acid and formic acid at a 30:70 ratio, followed by stirring overnight. The mixtures were stirred for 4 h before electrospinning, followed by 20 min of ultrasonication. The PCL/CS solution was then combined with 7% w/v NS solution (5 mL), and the mixture was stirred for 3 h. Once these parameters were in place, the flow rate for electrospinning was set at 0.5% per hour, the applied voltage was set at 18 kilovolts, the tip–collector distance was set at 12 cm, and the drum collector’s rotation speed was fixed at 700 rpm [37].

2.4. Characterization of the PCL/CS/NS Nanofibrous Scaffold

2.4.1. Morphological Analysis Using SEM

SEM (MIRA TESCAN, Czech Republic) was used to examine the morphology of the composite nanofibrous scaffold at a 15 kV accelerating voltage. The scaffolds were coated with gold before imaging using a sputter coater with a 15 kV acceleration voltage and a magnification scale of 100,000× g. Scaffold fiber diameters were calculated using image analysis software based on SEM images at 5000× g magnification (ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA).

2.4.2. Infrared Spectroscopy with Fourier Transform

PCL/PLA/NS nanofibers were obtained by combining 1 mg of sample with 100 mg of KBr of NS and using FTIR spectroscopy to analyze the structure and chemical makeup of the nanofiber, as well as any potential interactions between the extract and polymer in the nanofiber formations. In the 500–4000 cm−1 region, sample spectra were captured.

2.4.3. Water Contact Angle and Mechanical Properties

The water contact angle and mechanical features of the scaffolds were assessed.
The contact angle was dynamically calculated using the Wilhelm plate approach [38]. The hydrophilicity or hydrophobicity of the sample was tested and evaluated using water with a surface tension of 72 dyn/cm. The liquid in the container increased until the metal plate’s intended surface was completely submerged in water, at which point it began to descend. We determined the porosity of the fibers by weighing the samples and soaking them in PBS for 24 h. The weight was once more measured after the surface water and nanofiber web were eliminated from the solution. The nanofibrous scaffold’s porosity was determined by the volume of liquid that it could retain.

2.5. In Vitro Cell Culture Studies

The MTT test was carried out to identify the cytoprotective criteria of PCL/CS/NS nanofibrous mats under conditions of oxidative stress. To encourage cell adhesion on the nanofiber surface, 1 cm2 nanofibrous mats were sterilized overnight in a laminar flow hood under UV light for both the top and bottom surfaces. After being rinsed with distilled water and PBS to remove any remaining solvent, they were then submerged in DMEM overnight. Cells from L929 were cultured in DMEM supplemented with 10% FBS and 1% antibiotics at 37 °C and 5% carbon dioxide. The L929 cells were trypsinized and seeded at 1 × 105 cells per well onto the nanofibrous mat once they had attained % confluence. They were then incubated at 37 °C and 5% CO2. The MTT assay was used to test cell viability on the nanofibrous mats for 24, 48, and 72 h time periods.

2.6. Antibacterial Activity

The Kirby–Bauer disk diffusion method to test antibacterial activity (Humphries et al., 2018) [39] was considered a suitable method for evaluating the antibacterial activity of PCL/CS/NS nanofibers. Briefly, five bacterial colonies of S. aureus (ATCC 29213) and E. coli (ATCC 35218) were used to collect sterile inoculating loops, which were then suspended in 2 mL of sterilized PBS. By diluting the bacterial suspension with sterile PBS, the turbidity was already reduced to a 0.5 McFarland level. Inoculum channels were populated with sterile swabs. Bacterial swabs were inoculated into plates of Muller–Hinton agar. To disperse the nanofibers, we dissolved 0.1 mg PCL/CS/NS nanofibers in 1 mL of distilled water. Before use, the suspension was sonicated for 10 min. The standard was impregnated with 35 µL of the PCL/CS/NS nanofiber suspension, chitosan suspension, Nigella sativa extract (NS), distilled water (as a negative control), and antibiotic (as a positive control).

2.7. Activity of DPPH Radical Scavenging

This test was performed according to Blois’s description (1958) [40]. A total of 0.025 g/L of DPPH was dissolved in methanol. Dimethyl sulfoxide (DMSO) was used to dilute various concentrations of chitosan (CS), Nigella sativa (NS), nanofibers (PCL/CS/NS), and ascorbic acid (as a control) to create a sample solution. Following the addition of 5 µL of the sample solution to each well of a 96-well plate, 195 µL of the DPPH working suspension was pipetted. The reaction took place at room temperature for 20 min, and the solution’s absorbance at 515 nm was determined. The free radical scavenging activity of each fraction was assessed by comparing its absorbance to that of a blank solution (no sample). The following equation was used to calculate the percentage of inhibition, representing the capacity to scavenge DPPH radicals.
D P P   S c a v e n g i n g   A c t i v i t y % = ( A 0   A 1 ) / A 0 100
A0 refers to the absorbance value of the control and A1 represents the absorbance value of the test sample.

3. Results and Discussion

3.1. GC–MS Analysis

Multiple peaks were detected in the GC–MS analysis of the ethanolic extract of N. sativa seeds (Figure 1). A repository of the recognized component spectra from the GC–MS library was used to determine the chromatogram peaks. According to GC–MS profiling, the extract contained 20 major elements. The discovered compounds are listed in Table 1, along with their peak area (%), retention time, chemical formula, and molecular weight. From these 20 compounds, six elements had a high peak percentage, including hexadecanoic acid–methyl ester, undedecanoic acid, L-ascorbic acid 2,6-dihexadecanoate, 9,12-octadecadienoic acid-(Z, Z)–methyl ester, 10,13-eicosadienoic acid, 9-octadecenoic acid (Z), 9,12-octadecadienoic acid, and ethyl ester (Table 1). Hexadecanoic acid–methyl ester and 10,13-eicosadienoic acid–methyl ester are natural acids with antifungal and antibacterial properties, particularly against E. coli and Staphylococcus aureus [41]. Moreover, L-(+)- ascorbic acid 2,6-dihexadecanoate is an essential molecule that functions as an antioxidant, cardiovascular protectant, cancer-preventative, and flavoring agent [42]. Meanwhile, 9,12-octadecadienoic acid (Z, Z)–methyl ester has analgesic, anti-inflammatory, and ulcerative characteristics [43]. This polyunsaturated fatty acid is found in many plant glycosides, including Nigella sativa [44]. Among their various roles in the body, polyunsaturated fatty acids play a key role in anti-inflammation, antioxidant, and anti-atherosclerotic activities via the regulation of vascular hemodynamics [45].

3.2. Morphology of Nanofibers

SEM micrographs showed the prepared PCL/CS/NS at various weight ratios. From Figure 2, the nanofiber mat had a more uniform and thinner texture, demonstrating that a uniformly favorable solution viscosity was achieved during electrospinning by using the optimized operating parameters. The current study results revealed nanofibers of a diameter between 40 ± 2.03 and 180 ± 2.16 nm, with an average of 101.85 ± 4.38 nm. The morphology of the prepared electrospun nanofibers was directly influenced by parameters such as the voltage, flow rate, and the distance from the tip to the collector.
CS and NS have many polar groups, such as –NH2 and –COOH, which have the potential to carry positive or negative charges and create a polyanion–polycation complex. A larger charge density on the surface would result in more elongation forces being applied to the released jet [46]. Additionally, the increased charge density may increase the jet bending instability, resulting in a reduced fiber diameter [47]. Incorporating N. sativa into PCL/CS nanofibers resulted in shifting the fibers’ diameter and diameter distribution to lower values, which was in agreement with other previous reports [33].
The mechanical properties of PCL nanofibers have been enhanced through the addition of various fillers, including nanosilicates, graphene, cellulose nanocrystals, and Ag nanoparticles [48,49]. The mechanical strength of PCL nanofibers for biomedical applications has also been improved by blending them with natural or synthetic polymers [50]. Wang et al. (2021) [51] reported that adding natural polymers such as chitosan, alginate, and lignin to PCL nanofibers can improve their structural integrity, and hence their functionality. Since thymol was the active component of the NS extract, it stands to reason that this extract could serve as a plasticizer and regulator of the polymer chains, resulting in a reduction in the diameter of the nanofibers [52].
The shear viscosity of the spinning solution is often believed to be the key variable of the fiber diameter [53]. When the viscosity is too low, polymeric fibers and droplets of the material (electrospray) may be interrupted, while, when the viscosity is too high, the polymeric material cannot be extruded [54]. The needed minimum viscosity threshold varies with the molecular weight of the polymer and the type of solvent being employed and correlates with a certain polymer concentration in the electrospun solution [55]. PCL and CS are polymers with significantly different chemical properties and finding a common solvent to create a film was an important challenge. Additionally, it was crucial to maintain the optimal viscosity in order to create the double porous membrane structure. By increasing the chitosan ratio, it was possible to electrospin PCL/chitosan blends, and SEM pictures revealed that as the chitosan ratio increased, the fiber diameter and dispersion reduced. According to Roozbahani, Fatemeh et al., PCL-treated chitosan nanofibers with a 70/30 ratio have a smaller average diameter of 205 nm than blended nanofibers made from untreated chitosan, which has a 356 nm diameter [56].

3.3. FTIR Analysis

FTIR analysis was used to determine how electrospinning altered the parts that made up the PCL/CS/NS. The spectra of the PCL/CS/NS are shown in Figure 3. Prior research [57] revealed that the asymmetric and symmetric CH2 stretching peaks of the pure PCL membrane were at 2955 cm−1 and 2875 cm−1, the CO stretching peak was at 1735 cm−1, the asymmetric COC stretching peak was at 1260 cm−1, and the symmetric CH2 stretching peak was at 1164 cm−1 (CC stretching). The broad peak at 3451 cm−1 that distinguished PCL from the PCL/CS/NS spectrum was caused by the stretching vibration of -OH and -NH2 from CS [58]. However, the PCL/CS/NS composite membrane’s peaks were increased to 1500 cm−1 as a result of the peaks in the visible region of Figure 4 that belonged to NS [59]. This demonstrated that bioactive materials were electrospun into the PCL/CS/NS composite.

3.4. Water Contact Angle and Porosity Results

Wettability is an essential factor to consider when choosing a wound dressing since it influences cell adherence, proliferation, and the ability to absorb exudates. The water contact angle can be used to determine the wettability of a surface. The water contact angle was measured to determine the behavior of the composite PCL/CS/NS mats and to assess the hydrophilicity alterations in the nanocomposite scaffolds. As presented in Table 2, the PCL film exhibited poor hydrophilicity, with an average contact angle of 122.5°, which was in line with the hydrophobic nature of the polymer.
The contact angle value of PCL at 8% decreased to 99.4°, and then to 53.2°, after the addition of CS at 2% and NS at 10%, respectively. Results of the wettability test demonstrated that the incorporation of NS and CS within the PCL matrix may have produced some hydrophilic groups, such as NH and OH, on the surfaces of the nanocomposite membranes. The results of the mechanical properties are displayed in Table 3. The PCL/CS/NS nanofiber mat’s tensile strength was 5.4 ± 0.2 MPa, which was higher than the range of 1.8 ± 0.1 MPa for the PCL nanofibers alone, and was in line with earlier studies [60].

3.5. In Vitro Cell Culture Studies

The MTT test was used to determine the impact of PCL/CS/NS nanofiber scaffolds on the viability of L929 cells. The viability of the PCL/CS/NS scaffolds is shown in Figure 5 at 24, 48, and 72 h. As shown in the graph, the growth rate of the PCL/CS/NS nanocomposite scaffold was significantly higher than that of PCL, PCL/CS, and PCL/NS, and it approached that of the control sample by the end of the third day. The PCL/CS/NS scaffold’s fibers had very small diameters compared to pure PCL fibers, providing an appropriate space for cells to be placed. Furthermore, according to the test for determining scaffold hydrophilicity, adding NS to the polymer solution significantly increased the scaffold’s hydrophilicity, resulting in better cell adhesion to the scaffold. In a study conducted by Zagórska-Dziok, Martyna et al., N. sativa was found to have no cytotoxic effect on keratinocytes and fibroblasts, at concentrations of 1–1000 μg/mL [61]. Given these findings, it is reasonable to conclude that the PCL/CS/NS scaffold, at the ratio of 3/1/2, is a good option for cell culture because it increased the rate of proliferation of L929 cells over time [62]. This is consistent with the findings of Uddin et al. 2022 [63], who proved that, according to their MTT results, NS-containing composite mats were non-cytotoxic and increased fibroblast migration and proliferation.

3.6. Antibacterial Activity

An antibacterial evaluation was conducted using a disk diffusion technique for each bacterium. The diameter of the inhibition zone was measured after 24 h of incubation by a caliper. As shown in Figure 6, the prepared PCL/CS nanofiber mats containing NS had better antibacterial properties than PCL and PCL/CS. The results of the current study showed a notable inhibition zone of 8.00 ± 0.22 mm and 7.4 ± 0.16 mm for S. aureus and E. coli, respectively. The inhibition zone diameter was used as an index of the scaffold’s antibacterial activity in the disk diffusion test; the inhibition zone diameter of the mats containing PCL/CS/NS against S. aureus (Gram-positive) was greater than for E. coli (Gram-negative bacteria). Ciprofloxacin at 10 µg/mL was used as a positive control. According to the antibacterial activity test results of the present study, the inclusion of NS in the composite scaffold promoted antibacterial activity. Gram-positive bacteria are sensitive to these mats, and these results were in agreement with a result previously reported by Shahverdi et al. 2022 [64]. The antibacterial action of N. sativa seed extract may cause bacterial cell membranes to become permeable, resulting in cell destabilization and death [65]. Gram-negative bacteria are more resistant because their cell membranes are double-layered, as opposed to Gram-positive bacteria’s single-layer membranes [66,67].

3.7. Antioxidant Activity

Figure 6 depicts the 2,2-diphenyl-1-picrylhydrazyl (DPPH) method used to assess the antioxidant properties of the prepared nanofibrous mats. The free radical scavenging capacities were measured using the DPPH assay. Scavenging is most effective with electron or hydrogen donor scaffolds that quench and stabilize DPPH to DPPH-H. NS-containing scaffolds demonstrated dose-dependent scavenging potency comparable to ascorbic acid (p ≤ 0.005) (Table 4). Large amounts of ROS are produced during inflammation, causing biological damage such as lipid, protein, and nucleic acid degradation, and ultimately cell death, which disrupts the recovery process. The use of antioxidants can significantly aid enzymatic repair and metabolism [68]. Many studies have demonstrated that biogenic nanomaterials are a consistent source of antioxidant activity [69,70].
Previous studies have experimented with various extraction methods, including the DPPH scavenging assay, for extracts of N. sativa seeds [71]. In addition to beta-sitosterol, the NS seed extract contains significant amounts of other antioxidants, such as various tocopherol and tocotrienol isomers found in the alpha, beta, gamma, and delta forms. Another study found that an ethanolic extract of N. sativa seeds inhibited the DPPH scavenging assay by a higher percentage than a methanolic extract, which inhibited the assay by only 3.77% [72].
The current study’s findings are in excellent agreement with those of other investigations. Arif et al. (2021) [73] found that nanosuspensions of N. sativa extracts had the highest free radical scavenging activity of up to 55% at doses of 1000 mg/mL, and the lowest activity of up to 28% at 250 mg/mL. This work demonstrated that the DPPH free radical scavenging activity was greatly enhanced by increasing the quantities of the nanosuspensions and N. sativa extracts. The maximal amount of free radical scavenging activity for nanosuspensions of N. sativa extract was seen at 500 g/mL, according Ali et al. [74]. Thus, the DPPH free radical scavenging activity was dramatically improved by increasing the quantities of the nanofibrous mat.

4. Conclusions

According to the research’s findings, Nigella sativa-loaded PCL/CH electrospun nanofibers formed a new nanofibrous scaffold that was discovered to be non-toxic to skin L929 fibroblast cells. The production method resulted in thin fibers with mean diameters as low as 82 nm, high porosity, promising tensile strength, enhanced hydrophilicity, and biocompatibility. The incorporation of N. sativa into the PCL/CH matrix was supported by the findings of the chemical investigation of the nanofibrous composite by FTIR spectroscopy and structural XRD analysis.
The results of the cell viability test, which showed this formulation’s great bio-compatibility, were supported by the MTT assay. The inclusion of Nigella sativa extract also decreases the diameter of nanofibers. It also improves the antioxidant and antibacterial properties.

Author Contributions

Q.S.K. and H.A.-K. were responsible for the conceptualization and methodology; H.A.-K. conducted the formal analysis; N.A. and J.A.-S. were responsible for the investigation and data curation; H.A.-K., Q.S.K. and N.A. contributed to the study validation; S.A., H.A.-K., Q.S.K. and N.A. were involved in the visualization and original draft preparation; H.A.-K., S.A. and J.A.-S. worked on the writing, review, and editing; Q.S.K. and H.A.-K. assumed supervisory responsibilities; and Q.S.K. undertook project administration. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Acknowledgments

The authors extend their appreciation to the College of Basic Education, University of Babylon, Babylon, Iraq; the Laboratory of Multifunctional Materials and Applications (LaMMA), LR16ES18, Faculty of Sciences of Sfax, University of Sfax; the College of Veterinary Medicine, University of Al-Qadisiyah, Al-Diwaniyah, Iraq; the Department of Chemistry, College of Science, University of Misan, Maysan 62001, Iraq; and the College of Medicine, University of Warith Al-Anbiyaa, Karbala, Iraq, for their support.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Medeiros, G.B.; Lima, F.d.A.; de Almeida, D.S.; Guerra, V.G.; Aguiar, M.L. Modification and Functionalization of Fibers Formed by Electrospinning: A Review. Membranes 2022, 12, 861. [Google Scholar] [CrossRef]
  2. Xue, J.; Wu, T.; Dai, Y.; Xia, Y. Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications. Chem. Rev. 2019, 119, 5298–5415. [Google Scholar]
  3. Albukhaty, S.; Al-Karagoly, H.; Allafchian, A.R.; Jalali, S.A.H.; Al-Kelabi, T.; Muhannad, M. Production and characterization of biocompatible nanofibrous scaffolds made of β-sitosterol loaded polyvinyl alcohol/tragacanth gum composites. Nanotechnology 2021, 33, 085102. [Google Scholar] [CrossRef]
  4. Castro, K.C.; Campos, M.G.N.; Mei, L.H.I. Hyaluronic Acid Electrospinning: Challenges, Applications in Wound Dressings and New Perspectives. Int. J. Biol. Macromol. 2021, 173, 251–266. [Google Scholar] [CrossRef] [PubMed]
  5. Han, D.K.; Park, K.D.; Hubbell, J.A.; Kim, Y.H. Surface Characteristics and Biocompatibility of Lactide-Based Poly(Ethylene Glycol) Scaffolds for Tissue Engineering. J. Biomater. Sci. Polym. Ed. 1998, 9, 667–680. [Google Scholar] [PubMed]
  6. Liu, H.; Gough, C.R.; Deng, Q.; Gu, Z.; Wang, F.; Hu, X. Recent Advances in Electrospun Sustainable Composites for Biomedical, Environmental, Energy, and Packaging Applications. Int. J. Mol. Sci. 2020, 21, 4019. [Google Scholar] [CrossRef] [PubMed]
  7. Katti, D.S.; Robinson, K.W.; Ko, F.K.; Laurencin, C.T. Bioresorbable nanofiber-based systems for wound healing and drug delivery: Optimization of fabrication parameters. J. Biomed. Mater. Res. Part B 2004, 70B, 286–296. [Google Scholar] [CrossRef] [PubMed]
  8. Chou, S.F.; Carson, D.; Woodrow, K.A. Current strategies for sustaining drug release from electrospun nanofibers. J. Controlled Release 2015, 220, 584–591. [Google Scholar] [CrossRef]
  9. Wang, C.; Wang, J.; Zeng, L.; Qiao, Z.; Liu, X.; Liu, H.; Zhang, J.; Ding, J. Fabrication of Electrospun Polymer Nanofibers with Diverse Morphologies. Molecules 2019, 24, 834. [Google Scholar] [CrossRef]
  10. Malikmammadov, E.; Tanir, T.E.; Kiziltay, A.; Hasirci, V.; Hasirci, N. PCL and PCL-based materials in biomedical applications. J. Biomater. Sci. Polym. Ed. 2018, 29, 863–893. [Google Scholar] [CrossRef]
  11. Bharadwaz, A.; Jayasuriya, A.C. Recent Trends in the Application of Widely Used Natural and Synthetic Polymer Nanocomposites in Bone Tissue Regeneration. Mater. Sci. Eng. C Mater. Biol. Appl. 2020, 110, 110698. [Google Scholar] [CrossRef] [PubMed]
  12. Mochane, M.J.; Motsoeneng, T.S.; Sadiku, E.R.; Mokhena, T.C.; Sefadi, J.S. Morphology and Properties of Electrospun PCL and Its Composites for Medical Applications: A Mini Review. Appl. Sci. 2019, 9, 2205. [Google Scholar] [CrossRef]
  13. Dulnik, J.; Denis, P.; Sajkiewicz, P.; Kolbuk, D.; Choińska, E. Biodegradation of biocomponent PCL/gelatin and PCL/collagen nanofibers electrospun from alternative solvent system. Polym. Degrad. Stab. 2016, 130, 10–21. [Google Scholar] [CrossRef]
  14. Wu, G.; Deng, X.; Song, J.; Chen, F. Enhanced biological properties of biomimetic apatite fabricated polycaprolactone/chitosan nanofibrous bio-composite for tendon and ligament regeneration. J. Photochem. Photobiol. B 2018, 178, 27–32. [Google Scholar] [CrossRef]
  15. Miguel, P.S.; Ribeiro, M.P.; Coutinho, P.; Correia, I.J. Electrospun polycaprolactone/aloe vera chitosan nanofibrous asymmetric membranes aimed for wound healing applications. Polymers 2017, 9, 183. [Google Scholar] [CrossRef] [PubMed]
  16. Al-Musawi, S.; Albukhaty, S.; Al-Karagoly, H.; Sulaiman, G.M.; Alwahibi, M.S.; Dewir, Y.H.; Soliman, D.A.; Rizwana, H. Antibacterial Activity of Honey/Chitosan Nanofibers Loaded with Capsaicin and Gold Nanoparticles for Wound Dressing. Molecules 2020, 25, 4770. [Google Scholar] [CrossRef]
  17. Mouro, C.; Simões, M.; Gouveia, I.C. Emulsion Electrospun Fiber Mats of PCL/PVA/Chitosan and Eugenol for Wound Dressing Applications. Adv. Polym. Technol. 2019, 2019, 9859506. [Google Scholar] [CrossRef]
  18. Asghari, F.; Rabiei Faradonbeh, D.; Malekshahi, Z.V.; Nekounam, H.; Ghaemi, B.; Yousefpoor, Y.; Ghanbari, H.; Faridi-Majidi, R. Hybrid PCL/Chitosan-PEO Nanofibrous Scaffolds Incorporated with A. Euchroma Extract for Skin Tissue Engineering Application. Carbohydr. Polym. 2022, 278, 118926. [Google Scholar] [CrossRef]
  19. Al-Attass, S.A.; Zahran, F.M.; Turkistany, S.A. Nigella sativa and its active constituent thymoquinone in oral health. Saudi Med. J. 2016, 37, 235–244. [Google Scholar] [CrossRef]
  20. Mekhemar, M.; Hassan, Y.; Dörfer, C. Nigella sativa and Thymoquinone: A Natural Blessing for Periodontal Therapy. Antioxidants 2020, 9, 1260. [Google Scholar] [CrossRef]
  21. Abu-Al-Basalc, M.A. In vitro and iin vivo anti-microbial effects of Nigella sativa Linn. seed extracts against clinical isolates from skin wound infections. Am. J. Appl. Sci. 2009, 6, 1440. [Google Scholar]
  22. Amin, B.; Hosseinzadeh, H. Black cumin (Nigella sativa) and its active constituent, thymoquinone: An overview on the analgesic and anti-inflammatory effects. Planta Med. 2016, 82, 8–16. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Ahmad, A.; Husain, A.; Mujeeb, M.; Khan, S.A.; Najmi, A.K.; Siddique, N.A.; Damanhouri, Z.A.; Anwar, F. A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pac. J. Trop. Biomed. 2013, 3, 337–352. [Google Scholar] [CrossRef] [PubMed]
  24. Toma, C.-C.; Olah, N.-K.; Vlase, L.; Mogoșan, C.; Mocan, A. Comparative Studies on Polyphenolic Composition, Antioxidant and Diuretic Effects of Nigella sativa L. (Black Cumin) and Nigella damascena L. (Lady-in-a-Mist) Seeds. Molecules 2015, 20, 9560–9574. [Google Scholar] [CrossRef]
  25. Jihad, M.A.; Noori, F.T.M.; Jabir, M.S.; Albukhaty, S.; AlMalki, F.A.; Alyamani, A.A. Polyethylene Glycol Functionalized Graphene Oxide Nanoparticles Loaded with Nigella sativa Extract: A Smart Antibacterial Therapeutic Drug Delivery System. Molecules 2021, 26, 3067. [Google Scholar] [CrossRef]
  26. Rooney, S.; Ryan, M.F. Effects of alpha-hederin and thymoquinone, constituents of Nigella sativa, on human cancer cell lines. Anticancer Res. 2005, 25, 2199–2204. [Google Scholar]
  27. Chaudhry, H.; Fatima, N.; Ahmad, I.Z. Evaluation of antioxidant and antibacterial potential of Nigella sativa L. suspension culture under elicitation. BioMed Res. Int. 2015, 5, 708691. [Google Scholar]
  28. Al-Ghamdi, M.S. The anti-inflammatory, analgesic and antipyretic activity of Nigella sativa. J. Ethnopharmacol. 2001, 76, 45–48. [Google Scholar] [CrossRef] [PubMed]
  29. Abd El-Hack, M.E.; Alagawany, M.; Farag, M.R.; Tiwari, R.; Karthik, K.; Dhama, K. Nutritional, healthical and therapeutic efficacy of black cumin (Nigella sativa) in animals, poultry and humans. Int. J. Pharmacol. 2016, 12, 232–248. [Google Scholar] [CrossRef]
  30. Abbas Ali, M.M.; Abu Sayeed, M.; Shahinur Alam, M.; Sarmina Yeasmin, A.; Mohal Khan, A.; Muhamad, I. Characteristics of oils and nutrient contents of Nigella sativa Linn. and Trigonella foenum-graecum seeds. Bull. Chem. Soc. Ethiop. 2012, 26, 55–64. [Google Scholar] [CrossRef]
  31. Teilaghi, S.; Movaffagh, J.; Bayat, Z. Preparation as Well as Evaluation of the Nanofiber Membrane Loaded with Nigella sativa Extract Using the Electrospinning Method. J. Polym. Environ. 2020, 28, 1614–1625. [Google Scholar] [CrossRef]
  32. Kalhori, F.; Arkan, E.; Dabirian, F.; Abdi, G.; Moradipour, P. Controlled preparation and characterization of Nigella sativa electrospun pad for controlled release. Silicon 2019, 15, 593–601. [Google Scholar] [CrossRef]
  33. Aras, C.; Tümay Özer, E.; Göktalay, G.; Saat, G.; Karaca, E. Evaluation of Nigella sativa oil loaded electrospun polyurethane nanofibrous mat as wound dressing. J. Biomater. Sci. Polym. Ed. 2021, 32, 1718–1735. [Google Scholar] [CrossRef]
  34. Mahmoudvand, H.; Asadi, A.; Harandi, M.F.; Sharififar, F.; Jahanbakhsh, S.; Dezaki, E.S. In vitro lethal effects of various extracts of Nigella sativa seed on hydatid cyst protoscoleces. Iran. J. Basic Med. Sci. 2014, 17, 1001. [Google Scholar] [PubMed]
  35. Zeer, A.; George, N. GC-MS analysis of n-hexane extract of Nigella sativa (seeds). Saudi J. Med. Pharm. Sci. 2017, 3, 868–872. [Google Scholar]
  36. Jabeen, N.S.; Jagapriya, L.; Balasubramanian, S.; Devi, K.; Jeevanandam, J. Phytochemical analysis of nigella sativa L. seeds aqueous extract by gas chromatography-mass spectroscopy and Fourier-transform infrared. In Phytochemistry; Apple Academic Press: Palm Bay, FL, USA, 2018; pp. 587–604. [Google Scholar]
  37. Reshmi, C.; Suja, P.; Manaf, O.; Sanu, P.; Sujith, A. Nanochitosan enriched poly ε-caprolactone electrospun wound dressing membranes: A fine tuning of physicochemical properties, hemocompatibility and curcumin release profile. Int. J. Biol. Macromol. 2018, 108, 1261–1272. [Google Scholar]
  38. Karim, A.M.; Kavehpour, H.P. Effect of viscous force on dynamic contact angle measurement using Wilhelmy plate method. Colloids Surf. A Physicochem. Eng. Asp. 2018, 548, 54–60. [Google Scholar] [CrossRef]
  39. Humphries, R.M.; Kircher, S.; Ferrell, A.; Krause, K.M.; Malherbe, R.; Hsiung, A.; Burnham, C.-A.D. The continued value of disk diffusion for assessing antimicrobial susceptibility in clinical laboratories: Report from the Clinical and Laboratory Standards Institute Methods Development and Standardization Working Group. J. Clin. Microbiol. 2018, 56, e00437-18. [Google Scholar] [CrossRef]
  40. Blois, M.S. Antioxidant determinations by the use of a stable free radical. Nature 1958, 181, 1199–1200. [Google Scholar] [CrossRef]
  41. Davoodbasha, M.; Edachery, B.; Nooruddin, T.; Lee, S.Y.; Kim, J.W. An evidence of C16 fatty acid methyl esters extracted from microalga for effective antimicrobial and antioxidant property. Microb. Pathog. 2018, 115, 233–238. [Google Scholar] [CrossRef]
  42. Devasagayam, T.P.A.; Tilak, J.C.; Boloor, K.K.; Sane, K.S.; Ghaskadbi, S.S.; Lele, R.D. Free radicals and antioxidants in human health: Current status and future prospects. J. Assoc. Physicians India 2004, 52, 4. [Google Scholar]
  43. Ukwubile, C.A.; Ahmed, A.; Katsayal, U.A.; Yau, J.; Mejida, S. GC-MS analysis of bioactive from Melastomastrum capitatum Fern. Leaf methanol extract. An anticancer plant. Sci. Afr. 2019, 3, 900e. [Google Scholar] [CrossRef]
  44. Dalli, M.; Bekkouch, O.; Azizi, S.-e.; Azghar, A.; Gseyra, N.; Kim, B. Nigella sativa L. Phytochemistry and Pharmacological Activities: A Review (2019–2021). Biomolecules 2022, 12, 20. [Google Scholar] [CrossRef] [PubMed]
  45. Das, U.N. Essential fatty acids: Biochemistry, physiology and pathology. Biotechnol. J. 2006, 1, 420–439. [Google Scholar] [CrossRef] [PubMed]
  46. Feng, J.J. The stretching of an electrified non-Newtonian jet: A model for electrospinning. Phys. Fluids 2002, 14, 3912–3926. [Google Scholar] [CrossRef]
  47. Sajeev, U.; Anand, K.A.; Menon, D.; Nair, S. Control of nanostructures in PVA, PVA/chitosan blends and PCL through electrospinning. Bull. Mater. Sci. 2008, 31, 343–351. [Google Scholar] [CrossRef]
  48. Narayanan, G.; Gupta, B.S.; Tonelli, A.E. Enhanced mechanical properties of poly (ε-caprolactone) nanofibers produced by the addition of non-stoichiometric inclusion complexes of poly (ε-caprolactone) and α-cyclodextrin. Polymer 2015, 76, 321–330. [Google Scholar] [CrossRef]
  49. Guo, R.; Wang, R.; Yin, J.; Jiao, T.; Huang, H.; Zhao, X.; Zhang, L.; Li, Q.; Zhou, J.; Peng, Q. Fabrication and Highly Efficient Dye Removal Characterization of Beta-Cyclodextrin-Based Composite Polymer Fibers by Electrospinning. Nanomaterials 2019, 9, 127. [Google Scholar] [CrossRef]
  50. Arif, U.; Haider, S.; Haider, A.; Khan, N.; Alghyamah, A.A.; Jamila, N.; Khan, M.I.; Almasry, W.A.; Kang, I.K. Biocompatible Polymers and their Potential Biomedical Applications: A Review. Curr. Pharm. Des. 2019, 25, 3608–3619. [Google Scholar] [CrossRef] [PubMed]
  51. Wang, H.M.; Yuan, T.Q.; Song, G.Y.; Sun, R.C. Advanced and Versatile Lignin-Derived Biodegradable Composite Film Materials toward a Sustainable World. Green Chem. 2021, 23, 3790–3817. [Google Scholar] [CrossRef]
  52. Bangar, S.P.; Whiteside, W.S. Nano-cellulose reinforced starch bio composite films- A review on green composites. Int. J. Biol. Macromol. 2021, 185, 849–860. [Google Scholar] [CrossRef]
  53. Pakravan, M.; Heuzey, M.C.; Ajji, A. A fundamental study of chitosan/PEO electrospinning. Polymer 2011, 52, 4813–4824. [Google Scholar] [CrossRef]
  54. Grant, J.J.; Pillai, S.C.; Perova, T.S.; Hehir, S.; Hinder, S.J.; McAfee, M.; Breen, A. Electrospun Fibres of Chitosan/PVP for the Effective Chemotherapeutic Drug Delivery of 5-Fluorouracil. Chemosensors 2021, 9, 70. [Google Scholar] [CrossRef]
  55. Shenoy, S.L.; Bates, W.D.; Frisch, H.L.; Wnek, G.E. Role of chain entanglements on fiber formation during electrospinning of polymer solutions: Good solvent, non-specific polymer-polymer interaction limit. Polymer 2005, 46, 3372–3384. [Google Scholar] [CrossRef]
  56. Roozbahani, F.; Sultana, N.; Ismail, A.F.; Nouparvar, H. Effects of Chitosan Alkali Pretreatment on the Preparation of Electrospun PCL/Chitosan Blend Nanofibrous Scaffolds for Tissue Engineering Application. J. Nanomater. 2013, 2013, 1. [Google Scholar] [CrossRef]
  57. Al-Kaabi, W.J.; Albukhaty, S.; Al-Fartosy, A.J.M.; Al-Karagoly, H.K.; Al-Musawi, S.; Sulaiman, G.M.; Dewir, Y.H.; Alwahibi, M.S.; Soliman, D.A. Development of Inula graveolens (L.) Plant Extract Electrospun/Polycaprolactone Nanofibers: A Novel Material for Biomedical Application. Appl. Sci. 2021, 11, 828. [Google Scholar] [CrossRef]
  58. Cerrone, F.; Pozner, T.; Siddiqui, A.; Ceppi, P.; Winner, B.; Rajendiran, M.; Babu, R.; Ibrahim, H.S.; Rodriguez, B.J.; Winkler, J.; et al. Polyhydroxyphenylvalerate/polycaprolactone nanofibers improve the life-span and mechanoresponse of human IPSC-derived cortical neuronal cells. Mater. Sci. Eng. C 2020, 111, 110832. [Google Scholar] [CrossRef]
  59. Thabede, P.M.; Shooto, N.D.; Xaba, T.; Naidoo, E.B. Magnetite functionalized Nigella sativa seeds for the uptake of chromium (VI) and lead (II) ions from synthetic wastewater. Adsorp. Sci. Technol. 2021, 2021, 6655227. [Google Scholar] [CrossRef]
  60. Gao, S.; Guo, W.; Chen, M.; Yuan, Z.; Wang, M.; Zhang, Y.; Liu, S.; Xi, T.; Guo, Q. Fabrication and characteriza-tion of electrospun nanofibers composed of decellularized meniscus extracellular matrix and polycaprolactone for meniscus tissue engineering. J. Mater. Chem. B 2017, 5, 2273–2285. [Google Scholar] [CrossRef] [PubMed]
  61. Zagórska-Dziok, M.; Bujak, T.; Ziemlewska, A.; Nizioł-Łukaszewska, Z. Positive Effect of Cannabis sativa L. Herb Extracts on Skin Cells and Assessment of Cannabinoid-Based Hydrogels Properties. Molecules 2021, 26, 802. [Google Scholar] [CrossRef]
  62. Zhang, L.; Zheng, T.; Wu, L.; Han, Q.; Chen, S.; Kong, Y.; Li, G.; Ma, L.; Wu, H.; Zhao, Y.; et al. Fabrication and Characterization of 3D-Printed Gellan Gum/Starch Composite Scaffold for Schwann Cells Growth. Nanotechnol. Rev. 2021, 10, 50–61. [Google Scholar] [CrossRef]
  63. Uddin, M.N.; Mohebbullah, M.; Islam, S.M.; Uddin, M.A.; Jobaer, M. Nigella/honey/garlic/olive oil co-loaded PVA electrospun nanofibers for potential biomedical applications. Prog. Biomater. 2022, 11, 431–446. [Google Scholar] [CrossRef] [PubMed]
  64. Shahverdi, F.; Barati, A.; Salehi, E.; Arjomandzadegan, M. Biaxial electrospun nanofibers based on chitosan-poly (vinyl alcohol) and poly (Ɛ-caprolactone) modified with CeAlO3 nanoparticles as potential wound dressing materials. Int. J. Biol. Macromol. 2022, 221, 736–750. [Google Scholar] [CrossRef] [PubMed]
  65. Karagoly, H.; Rhyaf, A.; Naji, H.; Albukhaty, S.; AlMalki, F.A.; Alyamani, A.A.; Albaqami, J.; Aloufi, S. Green synthesis, characterization, cytotoxicity, and antimicrobial activity of iron oxide nanoparticles using Nigella sativa seed extract. Green Process. Synth. 2022, 11, 254–265. [Google Scholar] [CrossRef]
  66. Jabir, M.S.; Rashid, T.M.; Nayef, U.M.; Albukhaty, S.; AlMalki, F.A.; Albaqami, J.; AlYamani, A.A.; Taqi, Z.J.; Sulaiman, G.M. Inhibition of Staphylococcus aureus α-hemolysin production using nanocurcumin capped Au@ZnO nanocomposite. Bioinorg. Chem. Appl. 2022, 2022, 1–18. [Google Scholar] [CrossRef]
  67. Yang, X.; Zhang, W.; Qin, X.; Cui, M.; Guo, Y.; Wang, T.; Wang, K.; Shi, Z.; Zhang, C.; Li, W.; et al. Recent Progress on Bioinspired Antibacterial Surfaces for Biomedical Application. Biomimetics 2022, 7, 88. [Google Scholar] [CrossRef]
  68. Bryk, R.; Lima, C.D.; Erdjument-Bromage, H.; Tempst, P.; Nathan, C. Metabolic enzymes of mycobacteria linked to antioxidant defense by a thioredoxin-like protein. Science 2002, 295, 1073–1077. [Google Scholar] [CrossRef] [PubMed]
  69. Adebayo, E.A.; Ibikunle, J.B.; Oke, A.M.; Lateef, A.; Azeez, M.A.; Oluwatoyin, A.O.; Ayanfe Oluwa, A.V.; Blessing, O.T.; Comfort, O.O.; Adekunle, O.O. Antimicrobial and antioxidant activity of silver, gold and silver-gold alloy nanoparticles phytosynthesized using extract of Opuntia ficus-indica. Rev. Adv. Mater. Sci. 2019, 58, 313–326. [Google Scholar] [CrossRef]
  70. Khane, Y.; Benouis, K.; Albukhaty, S.; Sulaiman, G.M.; Abomughaid, M.M.; Al Ali, A.; Aouf, D.; Fenniche, F.; Khane, S.; Chaibi, W.; et al. Green Synthesis of Silver Nanoparticles Using Aqueous Citrus limon Zest Extract: Characterization and Evaluation of Their Antioxidant and Antimicrobial Properties. Nanomaterials 2022, 12, 2013. [Google Scholar] [CrossRef] [PubMed]
  71. Gueffai, A.; Gonzalez-Serrano, D.J.; Christodoulou, M.C.; Orellana-Palacios, J.C.; Ortega, M.L.S.; Ouldmoumna, A.; Kiari, F.Z.; Ioannou, G.D.; Kapnissi-Christodoulou, C.P.; Moreno, A.; et al. Phenolics from Defatted Black Cumin Seeds (Nigella sativa L.): Ultrasound-Assisted Extraction Optimization, Comparison, and Antioxidant Activity. Biomolecules 2022, 12, 1311. [Google Scholar] [CrossRef]
  72. Vahitha, V.; Karim, R.; Perinbam, K.; Hossain, S.J.; Basha, S.K.; Karim, R. Demonstration of Antioxidant, Antibacterial and Antifungal Property of Nigella Sativa Seed Extract. East Afr. Scholars J. Agric. Life Sci 2019, 4472, 1–6. [Google Scholar]
  73. Arif, S.; Saqib, H.; Mubashir, M.; Malik, S.I.; Mukhtar, A.; Saqib, S.; Ullah, S.; Show, P.L. Comparison of Nigella sativa and Trachyspermum ammi via experimental investigation and biotechnological potential. Chem. Eng. Process.-Process Intensif. 2021, 161, 108313. [Google Scholar] [CrossRef]
  74. Ali, T.; Hussain, F.; Naeem, M.; Khan, A.; Al-Harrasi, A. Nanotechnology approach for exploring the enhanced bioactivities and biochemical characterization of freshly prepared nigella sativa L. nanosuspensions and their phytochemical profile. Front. Bioeng. Biotechnol. 2022, 10, 888177. [Google Scholar] [CrossRef] [PubMed]
Figure 1. GC–MS chromatogram of the ethanol extract of Nigella sativa seeds.
Figure 1. GC–MS chromatogram of the ethanol extract of Nigella sativa seeds.
Biotech 12 00019 g001
Figure 2. Electrospun PCL/CS/NS (mean diameter 81.19 ± 4.38 nm) in a SEM photograph: (A) PCL (1 µm); (B) PCL/CS/NS (1 µm); (C) PCL/CS/NS (500 nm); (D) The diameter size distributions.
Figure 2. Electrospun PCL/CS/NS (mean diameter 81.19 ± 4.38 nm) in a SEM photograph: (A) PCL (1 µm); (B) PCL/CS/NS (1 µm); (C) PCL/CS/NS (500 nm); (D) The diameter size distributions.
Biotech 12 00019 g002
Figure 3. FTIR spectrum of PCL/CS/NS, PCL, CS, and NS extract.
Figure 3. FTIR spectrum of PCL/CS/NS, PCL, CS, and NS extract.
Biotech 12 00019 g003
Figure 4. (A) L929 cell viability percentages during different periods of time (24, 48, and 72 h). (B) L929 cytotoxicity percentages during different periods of time (24, 48, and 72 h).
Figure 4. (A) L929 cell viability percentages during different periods of time (24, 48, and 72 h). (B) L929 cytotoxicity percentages during different periods of time (24, 48, and 72 h).
Biotech 12 00019 g004
Figure 5. Antimicrobial activity of PCL/CS/NS nanofibers against S. aureus and E. coli. Inhibition zones (mm): 1—antibiotic; 2—CS/NS; 3—PCL/CS; 4—PCL/CS/NS nanofibers; 5—PCL; 6—negative control (D.W.).
Figure 5. Antimicrobial activity of PCL/CS/NS nanofibers against S. aureus and E. coli. Inhibition zones (mm): 1—antibiotic; 2—CS/NS; 3—PCL/CS; 4—PCL/CS/NS nanofibers; 5—PCL; 6—negative control (D.W.).
Biotech 12 00019 g005
Figure 6. Percentage inhibition of DPPH radical in the presence of different concentrations of CS, NS, PCL/CS/NS nanofiber mats, and ascorbic acid.
Figure 6. Percentage inhibition of DPPH radical in the presence of different concentrations of CS, NS, PCL/CS/NS nanofiber mats, and ascorbic acid.
Biotech 12 00019 g006
Table 1. Retention time, phytochemical compounds, and peak area % determined by GC–MS analysis of Nigella sativa seed extract.
Table 1. Retention time, phytochemical compounds, and peak area % determined by GC–MS analysis of Nigella sativa seed extract.
Peak No.Ret. TimePhytochemical CompoundsMolecular FormulaMolecular WeightPeak Area %
15.603GlycerinC3H8O3920.47
218.622Phenol, 2,4-bis(1,1-dimethylethyl)-C14H22O2060.18
320.18Phenol, 2,4-bis(1,1-dimethylethyl)-C14H22O2060.82
424.244Phenol, 2,4-bis(1,1-dimethylethyl)-C14H22O2060.93
535.471Hexadecanoic acid, methyl esterC17H34O22700.73
635.5557,9-Di-tert-butyl-1-oxaspiro(4,5)deca-6,9-diene-2,8-dioneC17H24O32760.15
735.807Hexadecanoic acid, methyl esterC17H34O22700.52
836.575l-(+)-Ascorbic acid 2,6-dihexadecanoateC38H68O86524.24
936.823Pentadecanoic acidC15H30O22423.73
1037.284Hexadecanoic acid, ethyl esterC17H34O22700.82
1137.511Hexadecanoic acid, ethyl esterC17H34O22700.52
1239.7659,12-Octadecadienoic acid (Z,Z)-, methyl esterC19H34O22945.07
1339.92510,13-Eicosadienoic acid, methyl esterC21H38O23226.46
1440.0669-Octadecenoic acid (Z)-, methyl esterC19H36O22961.89
1540.573Methyl stearateC19H38O22980.23
1641.125Octadec-9-enoic acidC18H34O228247.64
1741.3869,12-Octadecadienoic acid, ethyl esterC20H36O23087.71
1841.4859,12-Octadecadienoic acid, ethyl esterC20H36O230816.71
1942.183Heptadecanoic acid, 15-methyl-, ethyl esterC20H40O23120.85
2042.26Heptadecanoic acid, 15-methyl-, ethyl esterC20H40O23120.32
Table 2. Hydrophobicity and electrospinning conditions of the electrospun nanofibers.
Table 2. Hydrophobicity and electrospinning conditions of the electrospun nanofibers.
SampleSolutions: RatioContact Angle (°)
(Hydrophilicity)
FR (mL/h)TCD (cm)Voltage (kV)
PCL-122.5° ± 2.00.52020
PC L/Cs 99.6° ± 4.00.52020
PCL/Cs/NS70:3053.2 ± 1.00.52020
Table 3. Physical properties of the PCL/CS/NS nanofibers after cross-linking (*: p < 0.05).
Table 3. Physical properties of the PCL/CS/NS nanofibers after cross-linking (*: p < 0.05).
SampleUltimate Tensile Strength (MPa)Contact Angle (°)
(Hydrophilicity)
PCL1.8 ± 0.1117.5 ± 2.0
PCL/Cs/NS5.4 ± 0.2 *121.8 ± 2.0 *
PCL/Cs3.4 ± 0.1118.2 ± 2.0
Table 4. DPPH inhibition (%) of different concentrations of PCL/CS/NS nanofiber mats.
Table 4. DPPH inhibition (%) of different concentrations of PCL/CS/NS nanofiber mats.
Concentration (µg/mL)CS %NS %NF %Ascorbic Acid %
1020.07918.10840.98641.23
2029.78730.6342.34250.01
3041.93537.9035057.14
4046.82549.20656.34968.74
5049.10753.96863.49277.18
6060.1563.88874.30684.94
7067.12368.21179.4791.41
8075.15977.84483.83296.01
9079.28980.66287.84599.01
10080.82984.45594.8186599.44
Mean55.02 A56.48 AB67.34 AB76.51 B
SD20.99 *22.51 *19.43 *21.31 *
LSD (p < 0.05) =19.13
Different letters between any two groups indicate a significant difference at p < 0.05.* CS = Chitosan; NS = Nigella sativa; NF = PCL/CS/NS nanofibers.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kahdim, Q.S.; Abdelmoula, N.; Al-Karagoly, H.; Albukhaty, S.; Al-Saaidi, J. Fabrication of a Polycaprolactone/Chitosan Nanofibrous Scaffold Loaded with Nigella sativa Extract for Biomedical Applications. BioTech 2023, 12, 19. https://doi.org/10.3390/biotech12010019

AMA Style

Kahdim QS, Abdelmoula N, Al-Karagoly H, Albukhaty S, Al-Saaidi J. Fabrication of a Polycaprolactone/Chitosan Nanofibrous Scaffold Loaded with Nigella sativa Extract for Biomedical Applications. BioTech. 2023; 12(1):19. https://doi.org/10.3390/biotech12010019

Chicago/Turabian Style

Kahdim, Qasim Shakir, Najmeddine Abdelmoula, Hassan Al-Karagoly, Salim Albukhaty, and Jabbar Al-Saaidi. 2023. "Fabrication of a Polycaprolactone/Chitosan Nanofibrous Scaffold Loaded with Nigella sativa Extract for Biomedical Applications" BioTech 12, no. 1: 19. https://doi.org/10.3390/biotech12010019

APA Style

Kahdim, Q. S., Abdelmoula, N., Al-Karagoly, H., Albukhaty, S., & Al-Saaidi, J. (2023). Fabrication of a Polycaprolactone/Chitosan Nanofibrous Scaffold Loaded with Nigella sativa Extract for Biomedical Applications. BioTech, 12(1), 19. https://doi.org/10.3390/biotech12010019

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop